Brimonidine
Product Images NDC 17478-715

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Brimonidine (NDC 17478-715). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Akorn, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bri01 0006 01

Chemical structure of the active ingredient Brimonidine. The diagram shows the molecular arrangement including a brominated bicyclic core linked to an imidazoline group, alongside the structure of a tartaric acid molecule, indicating the compound may be presented as a tartaric acid salt.*

FDA Label Image

Bri01 0006 02

Label for Brimonidine Tartrate Ophthalmic Solution 0.2%, 5 mL, by Akorn. The label includes the active ingredient concentration, preservative Benzalkonium Chloride 0.005%, storage instructions, manufacturer information, and an NDC number 17478-715-10. The label indicates the product is sterile and prescription only.*

FDA Label Image

Bri01 0006 03

Packaging label for Brimonidine Tartrate Ophthalmic Solution 0.2% by Akorn. The label shows NDC 17478-715-10 with a 5 mL sterile dosage form. It includes usage storage instructions, details on active ingredient concentration, preservatives, and inactive ingredients. The label prominently features the Akorn logo and barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.